BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
तुलना करने के लिए मीट्रिक्स | BLLN | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधBLLNपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 1,099.6x | −2.8x | −0.4x | |
PEG अनुपात | 10.87 | 0.00 | 0.00 | |
क़ीमत/बुक | 6.7x | 1.0x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 10.5x | 1.6x | 3.1x | |
अपसाइड (विश्लेषक लक्ष्य) | 68.2% | 196.0% | 58.2% | |
उचित मूल्य अपसाइड | अनलॉक करें | 24.8% | 8.5% | अनलॉक करें |